The Recall Desk
Agency classClass IIOur severity:SevereFDA (Devices)·Z-3206-2026·Announced 2026-09-23

Howmedica Recalls Scorpio Patella Implants Due to Polyethylene Wear Risk

Howmedica is recalling specific Scorpio patella implants because aged polyethylene material may cause excessive wear, leading to device failure and potential revision surgery.

The agency’s classification

FDA (Devices): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II and involves a structural defect in a medical implant that can lead to device fracture and the need for revision surgery, meeting the criteria for a Severe rating.

Plain-English summary

Howmedica Osteonics Corp. is recalling specific lots of SCORPIO C-DOME and U-DOME patella orthopaedic implant components. The affected devices were manufactured using Ultra High Molecular Weight Polyethylene (UHMWPE) raw material that was aged in excess of five years. The recall covers 12,156 units distributed in the United States and internationally, including Canada, LATAM, Europe, Asia Pacific, and South Africa.

The recall is due to the potential for elevated levels of oxidation in the aged polyethylene material. This oxidation may result in increased wear, which can lead to hazards such as excessive wear debris, material fragments, a fractured device, or a disassociated device. Potential harms associated with these failures include the need for revision surgery, pain, and inflammation.

Patients who have received these specific implant components should contact their orthopaedic surgeon to discuss the recall and determine if any follow-up care or monitoring is necessary. Healthcare providers should verify the specific lot numbers and UDI-DI codes against the recall list to identify affected patients.

The recalled product

Product
SCORPIO C-DOME PATELLA 73-2710 73-2910 SCORPIO U-DOME PATELLA 73-3110 73-3508 73-3708 73-3710 73-3910 Orthopaedic implant components manufactured from UHMWPE (polyethylene)
Affected units
12,156

Distribution

Distributed nationwide across the United States.

Similar recalls